Literature DB >> 20799337

Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males.

Stephen C Collins1, Steven M Bray, Joshua A Suhl, David J Cutler, Bradford Coffee, Michael E Zwick, Stephen T Warren.   

Abstract

Fragile X syndrome (FXS), the most common inherited form of developmental delay, is typically caused by CGG-repeat expansion in FMR1. However, little attention has been paid to sequence variants in FMR1. Through the use of pooled-template massively parallel sequencing, we identified 130 novel FMR1 sequence variants in a population of 963 developmentally delayed males without CGG-repeat expansion mutations. Among these, we identified a novel missense change, p.R138Q, which alters a conserved residue in the nuclear localization signal of FMRP. We have also identified three promoter mutations in this population, all of which significantly reduce in vitro levels of FMR1 transcription. Additionally, we identified 10 noncoding variants of possible functional significance in the introns and 3'-untranslated region of FMR1, including two predicted splice site mutations. These findings greatly expand the catalog of known FMR1 sequence variants and suggest that FMR1 sequence variants may represent an important cause of developmental delay.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20799337      PMCID: PMC2946449          DOI: 10.1002/ajmg.a.33626

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  66 in total

1.  In vitro DNA methylation inhibits FMR-1 promoter.

Authors:  W L Hwu; Y M Lee; S C Lee; T R Wang
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

2.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

Authors:  A J Verkerk; M Pieretti; J S Sutcliffe; Y H Fu; D P Kuhl; A Pizzuti; O Reiner; S Richards; M F Victoria; F P Zhang
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

3.  Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects.

Authors:  Paul D Thomas; Anish Kejariwal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

4.  A point mutation in the FMR-1 gene associated with fragile X mental retardation.

Authors:  K De Boulle; A J Verkerk; E Reyniers; L Vits; J Hendrickx; B Van Roy; F Van den Bos; E de Graaff; B A Oostra; P J Willems
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

5.  Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.

Authors:  Mariëtte Schrier; Lies-Anne Severijnen; Surya Reis; Maria Rife; Sandra van't Padje; Gert van Cappellen; Ben A Oostra; Rob Willemsen
Journal:  Exp Neurol       Date:  2004-10       Impact factor: 5.330

6.  Five years of molecular diagnosis of Fragile X syndrome (1997-2001): a collaborative study reporting 95% of the activity in France.

Authors:  Valérie Biancalana; Chérif Beldjord; Agnès Taillandier; Sylvie Szpiro-Tapia; Véronica Cusin; Fabienne Gerson; Christophe Philippe; Jean-Louis Mandel
Journal:  Am J Med Genet A       Date:  2004-09-01       Impact factor: 2.802

7.  Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat.

Authors:  C T Ashley; J S Sutcliffe; C B Kunst; H A Leiner; E E Eichler; D L Nelson; S T Warren
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

8.  No apparent involvement of the FMR1 gene in five patients with phenotypic manifestations of the fragile X syndrome.

Authors:  P Chiurazzi; E de Graaff; J Ng; A J Verkerk; S Wolfson; G S Fisch; L Kozak; G Neri; B A Oostra
Journal:  Am J Med Genet       Date:  1994-07-15

9.  DNA methylation represses FMR-1 transcription in fragile X syndrome.

Authors:  J S Sutcliffe; D L Nelson; F Zhang; M Pieretti; C T Caskey; D Saxe; S T Warren
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

10.  Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome.

Authors:  K A Lugenbeel; A M Peier; N L Carson; A E Chudley; D L Nelson
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

View more
  54 in total

1.  Excess variants in AFF2 detected by massively parallel sequencing of males with autism spectrum disorder.

Authors:  Kajari Mondal; Dhanya Ramachandran; Viren C Patel; Katie R Hagen; Promita Bose; David J Cutler; Michael E Zwick
Journal:  Hum Mol Genet       Date:  2012-07-05       Impact factor: 6.150

2.  Axonal ribosomes and mRNAs associate with fragile X granules in adult rodent and human brains.

Authors:  Michael R Akins; Hanna E Berk-Rauch; Kenneth Y Kwan; Molly E Mitchell; Katherine A Shepard; Lulu I T Korsak; Emily E Stackpole; Jennifer L Warner-Schmidt; Nenad Sestan; Heather A Cameron; Justin R Fallon
Journal:  Hum Mol Genet       Date:  2017-01-01       Impact factor: 6.150

Review 3.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

4.  Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.

Authors:  Leila K Myrick; Pan-Yue Deng; Hideharu Hashimoto; Young Mi Oh; Yongcheol Cho; Mickael J Poidevin; Joshua A Suhl; Jeannie Visootsak; Valeria Cavalli; Peng Jin; Xiaodong Cheng; Stephen T Warren; Vitaly A Klyachko
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

Review 5.  New perspectives on the biology of fragile X syndrome.

Authors:  Tao Wang; Steven M Bray; Stephen T Warren
Journal:  Curr Opin Genet Dev       Date:  2012-02-28       Impact factor: 5.578

Review 6.  Rare FMR1 gene mutations causing fragile X syndrome: A review.

Authors:  Adam F Sitzmann; Robert T Hagelstrom; Flora Tassone; Randi J Hagerman; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2017-11-27       Impact factor: 2.802

Review 7.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

8.  A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response.

Authors:  Roman Alpatov; Bluma J Lesch; Mika Nakamoto-Kinoshita; Andres Blanco; Shuzhen Chen; Alexandra Stützer; Karim J Armache; Matthew D Simon; Chao Xu; Muzaffar Ali; Jernej Murn; Sladjana Prisic; Tatiana G Kutateladze; Christopher R Vakoc; Jinrong Min; Robert E Kingston; Wolfgang Fischle; Stephen T Warren; David C Page; Yang Shi
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

9.  C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.

Authors:  Elaine Y Liu; Jenny Russ; Kathryn Wu; Donald Neal; Eunran Suh; Anna G McNally; David J Irwin; Vivianna M Van Deerlin; Edward B Lee
Journal:  Acta Neuropathol       Date:  2014-05-08       Impact factor: 17.088

Review 10.  The unstable repeats--three evolving faces of neurological disease.

Authors:  David L Nelson; Harry T Orr; Stephen T Warren
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.